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Res Syn Meth. 2018;1–19.Introduction: Rating the quality of a body of evidence is an increasingly com-
mon component of research syntheses on intervention effectiveness. This study
sought to identify and examine existing systems for rating the quality of a body
of evidence on the effectiveness of health and social interventions.
Methods: We used a multicomponent search strategy to search for full‐length
reports of systems for rating the quality of a body of evidence on the effective-
ness of health and social interventions published in English from 1995 onward.
Two independent reviewers extracted data from each eligible system on the evi-
dence domains included, as well as the development and dissemination pro-
cesses for each system.
Results: Seventeen systems met our eligibility criteria. Across systems, we
identified 13 discrete evidence domains: study design, study execution, consis-
tency, measures of precision, directness, publication bias, magnitude of effect,
dose‐response, plausible confounding, analogy, robustness, applicability, and
coherence. We found little reporting of rigorous procedures in the development
and dissemination of evidence rating systems.
Conclusion: We identified 17 systems for rating the quality of a body of evi-
dence on intervention effectiveness across health and social policy. Existing sys-
tems vary greatly in the domains they include and how they operationalize
domains, and most have important limitations in their development and dis-
semination. The construct of the quality of the body of evidence was defined
in a few systems largely extending the Grading of Recommendations Assess-
ment, Development, and Evaluation approach. Grading of Recommendations
Assessment, Development, and Evaluation was found to be unique in its com-
prehensive guidance, rigorous development, and dissemination strategy.
KEYWORDS
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2 MOVSISYAN ET AL.1 | INTRODUCTION
Rating the quality of a body of evidence is an increasingly
common component of systematic reviews and practice
guidelines on intervention effectiveness. While assessing
risks of bias in each individual study included in a research
synthesis is an important and well‐established practice,1,2
rating the quality of a body of evidence is a comparatively
new practice that indicates the credibility and trustworthi-
ness of the totality of evidence across studies in relation to
a specific research question.3,4 Systems for rating the quality
of a body of evidence have been predominantly discussed
and applied in health‐related systematic reviews and clini-
cal guideline development.5,6 The Cochrane Collaboration
was the first organization to attempt to integrate the rating
of a body of evidence as a mandatory procedure in research
syntheses on intervention effectiveness. Specifically,
Cochrane mandated use of the Grading of Recommenda-
tions Assessment, Development, and Evaluation (GRADE)
approach in the conduct of Cochrane intervention reviews.4
Over the last decade, GRADE and other approaches for
rating the quality of a body of evidence have proliferated.
The GRADE approach, specifically, is currently used by
over 100 organizations worldwide.7
Systems for rating the quality of a body of evidence typ-
ically involve an examination of various characteristics of
evidence that ultimately results in a rating of that body
of evidence. For example, in the GRADE approach, the
process of rating starts with a consideration of the designs
of included studies: If the body of evidence contributing
to an outcome consists of randomized controlled trials
(RCTs), the quality of a body of evidence is initially given
a rating of “high,” while a body of evidence consisting
of nonrandomized studies is initially given a rating of
“low.”8 The body of evidence is then assessed by consider-
ing 8 further domains. Assessments within 5 domains—
risk of bias, indirectness, inconsistency, imprecision, and
publication bias—are used to downgrade the initial rating.
For a body of evidence consisting of nonrandomized stud-
ies, assessments within the 3 remaining domains—magni-
tude of the effect, dose‐response relationship in the effect,
and counteracting plausible residual bias or confounding
—may be used to upgrade the initial “low” rating. Quality
(“certainty” is also another frequently used term) of evi-
dence is ultimately categorized into 1 of 4 ratings—high,
moderate, low, and very low—that reflect the extent to
which the review authors are confident or certain that an
estimate of the effect for a specific outcome is correct.8
As use of evidence rating systems has increased, so
have reports of challenges faced by those attempting to
use these systems—particularly for research syntheses
on social and public health interventions, which are often
described as “complex.”9-12 Interventions are viewed ascomplex for a variety of reasons. Some dimensions of
complexity are ascribed to aspects of the interventions
themselves,13,14 such as interventions with multiple com-
ponents that aim to address different and multiple causes
of the problems (eg, both biological and social). Other
dimensions of complexity are seen as emanating from sys-
tem properties,15 that is to say, long, nonlinear, and
dynamic relationships between interventions and out-
comes, interactions and interdependencies between dif-
ferent components of interventions, and levels of
target.16 Consideration of complexity may require addi-
tional guidance when rating the quality of a body of evi-
dence.11,12,17 Study design is often a key issue, given that
RCTs are not feasible or appropriate for many popula-
tion‐level interventions. In addition, many researchers
acknowledge that multifaceted heterogeneity between
studies in systematic reviews of complex interventions is
a more difficult type of problem and requires specific pro-
cedures of planning and analysis.18 There are also con-
cerns that narrow perspectives on evidence synthesis,
and the process of rating the quality of a body of evidence
with simple hypotheses about the causal relationships
may result in naïve and misleading synthesis results.19,20
Furthermore, there are ambiguities around how best to
conceptualize and interpret the construct of the quality
of the body of evidence on the effectiveness of an inter-
vention, when effects are contingent upon intervention
programming, implementation, and contextual factors.121.1 | Objectives
In view of the challenges reported in applying quality of a
body of evidence rating outside of biomedical settings and
interventions,11,12 this paper sets out to systematically
review systems for rating the quality of a body of evidence
on intervention effectiveness, including systems from
health and social policy. Previous systematic reviews
investigating evidence rating systems have mainly focused
on scientific evidence in biomedical contexts and have not
included systems from social policy domains such as pub-
lic health, education, and crime and justice.21,22
The key objectives of this systematic review therefore
are to (1) identify existing systems for rating the quality
of a body of evidence on intervention effectiveness across
health and social policy, (2) examine how these systems
describe the construct of the quality of a body of evidence
and map out discrete domains they use to rate that qual-
ity, and (3) describe the reported procedures used to
develop and disseminate the systems.
The resultant “state of the field” map of the systems
can be used by any reviewer to identify and adopt systems
and domains for rating the quality of a body of evidence
that are relevant for their specific needs.
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2.1 | Eligibility criteria
Methods of this systematic review are described in detail in
an a priori developed protocol (see Supporting Information).
To be included in this review, a system had to (1) comprise a
full‐length document reporting a procedure for rating the
quality of a body of evidence, derived from evidence synthesis
that integrates results across individual studies on the effec-
tiveness of health or social interventions, and (2) be pub-
lished in English from 1995 onward, when evidence rating
was first proposed as a stage of research synthesis.23 Where
a document discussed a system developed by others (eg, a
literature review), we retrieved the original documents
reporting those systems and examined them for eligibility.
We excluded documents if they described a procedure for
rating the quality of a body of evidence on intervention effec-
tiveness for a specific clinical topic (eg, systems used in spe-
cific guidelines on osteoarthritis and brain injury), as these
are largely covered by the 2 previous systematic reviews.21,22
We also excluded systems that were no longer used by an
organization (eg, the systems previously used by the Scottish
Intercollegiate Guidelines Network and the Institute for
Clinical Systems Improvement, before these organizations
adopted the GRADE approach). Information on suspended
use of these systems was either directly available on the
organization's website or was obtained through email com-
munication with representatives of the organization.2.2 | Systematic search strategy
We used a multicomponent search strategy with multiple
sources in an attempt to maximize the sensitivity of the
search. First, we updated search strategies used in previous
systematic reviews21,22 and expanded them to include
social science databases. We ran these searches on June 2,
2016 in the following databases: Applied Social Sciences
Index, Cochrane Methodology Register (Cochrane Library),
EMBASE, MEDLINE, PsycINFO, SCIE Social Care Online,
Scopus Social Sciences, and Social Sciences Citation Index
(Web of Knowledge). Next, using the expertise of the authors
and through bibliography searches of the related literature,
we located and searched the websites of 83 key stakeholder
organizations that specifically aim to aggregate, review, and
assess evidence across social policy domains, such as child
and family welfare, international development, crime and
justice, public health, and education (see Supporting Infor-
mation for the search strategy). Third, we searched the
bibliographies of all the included documents and literature
reviews containing secondary reporting of eligible systems.
Finally, we consulted experts identified from the website
searches to check whether we missed any systems.Screening of all titles, abstracts, and full‐text docu-
ments was conducted by the first author (AM) by using
the Rayyan web application for systematic reviews.24 A
subset of randomly chosen titles (10%) was independently
screened by a second author (JD). All discrepancies were
discussed until agreement was reached.2.3 | Data extraction
We extracted data on 4 types of information. First, we
extracted descriptive information about included systems,
namely, the author, year, title, publication source, and eligi-
bility criteria. We then extracted information from each sys-
tem on how its authors defined the construct of the quality
of a body of evidence. We further extracted details of
specific domains within the system used to rate the quality
of a body of evidence, how these domains were defined, and
how ratings of the quality of a body of evidencewere catego-
rized (eg, “high,” “moderate,” or “low”). Extending the
prespecified domains for development and dissemination
of research reporting guidelines,25,26 we looked at whether
the systems reported any preparatory activities, such as a
review of literature on existing domains for rating a body
of evidence and consensus‐based activities, such as a Delphi
exercise and expert meetings. Finally, we looked for infor-
mation on how the documents describing the systems were
written up and disseminated, such as whether the authors
of the systems described how they planned to address
criticism and feedback for the system or whether the system
was available on an open‐access website.
The first author (AM) and a second independent
reviewer (either JD or a research assistant) extracted infor-
mation about the content, development, and dissemination
of the included systems into a Microsoft Excel spreadsheet.
Three independent reviewers (AM, JD, and ER) piloted the
data extraction form on the same evidence rating system
before continuing with the remaining systems.2.4 | Data synthesis
We employed a 3‐step procedure to describe the domains
of evidence for rating the quality of a body of evidence in
the included systems. First, we created an inventory of all
identified domains by using cross‐case tables.27 We exam-
ined these tables to compare how the domains for rating
the quality of a body of evidence were labeled, defined,
and operationalized across included systems. We then
compiled a discrete (ie, nonredundant) list of domains of
evidence considered in the included systems. The systems
used different terminology to denote similar constructs
and domains of evidence (for example, aspects of the
domain that is termed as “imprecision” in the GRADE
approach were covered by “precision” in the system used
4 MOVSISYAN ET AL.by the Agency for Healthcare Research and Quality
[AHRQ] and fell under the domain termed “clinical
impact” in the system adopted by the National Health
and Medical Research Council of Australia). Where such
overlap existed, we mainly followed the terminology of
the GRADE approach to describe the discrete set of
domains. We supplemented this with a list of additional
domains that are not currently considered in the GRADE
approach, but were found in other systems, and followed
the terminology used in the systems to describe these
domains. Finally, to help readers to visualize findings,
we created a heat map summarizing how the systems
reported the identified discrete domains of evidence (see
Figure 1). By using different color shades, the heat map
describes whether these domains of evidence are reported
in each included system or not. Where a system reported
the domain and yet did not provide specific criteria andFIGURE 1 Reporting of the domains of evidence in the evidence rati
viewed at wileyonlinelibrary.com]
FIGURE 2 Reporting of the activities for developing and disseminat
[Colour figure can be viewed at wileyonlinelibrary.com]guidance for rating it, the map denotes those as a different
category of reporting (ie, with a brighter shade). Similar to
this, we developed a second heat map describing how the
authors reported activities underpinning the development
and dissemination of the included systems (see Figure 2).
Both of these heat maps were developed by first author
(AM) and further verified by the second author (JD).3 | RESULTS
We identified 11,758 records after duplicates were
removed. After title and abstract screening, we assessed
the full texts of 141 records, from which 28 records were
found to be eligible for inclusion in this review. Overall,
these 28 records describe 17 evidence rating systems
(see Figure 3 for the PRISMA flow diagram).ng systems for health and social interventions [Colour figure can be
ing the evidence rating systems for health and social interventions
FIGURE 3 Systematic review PRISMA
flow diagram
MOVSISYAN ET AL. 53.1 | Excluded studies
Of the 113 records excluded at full text, 45 involved lit-
erature reviews of evidence rating systems, 28 were edi-
torials or conference abstracts, and 4 records were not
published in English (Chinese, French, Portuguese,
and Spanish). Twenty‐nine records described procedures
and domains for categorizing interventions on websites
of different “what works” organizations, also known
as evidence clearinghouses or evidence‐based program
registers.28 Because these procedures and corresponding
domains of evidence did not consider a “body of evi-
dence,” we excluded them from this review (a full list
of these systems and their specific domains are avail-
able from the first author upon request). Through
website searches and contacts with experts, we
established that 6 systems were no longer used.23,29-33
A further system, the Confidence in the Evidence from
Reviews of Qualitative Research, which is designed for
sole application to a body of qualitative evidence, was
not eligible for use in assessment of effectiveness
evidence.34
3.2 | Characteristics of the sample
Fourteen of the included systems were developed for
healthcare, including general clinical and public health
interventions (see Table 1). Only 3 systems were devel-
oped for other policy domains—specifically education,
criminology, and international development.35-37 Three
of the included systems were largely based on the GRADE
approach38 but introduced modifications that warrant
their classification as separate systems.39-41 Ten systemsmentioned specific research synthesis methods for which
the system was developed; most referred to a meta‐analy-
sis or a “narrative synthesis” without a single pooled
effect estimate42 to synthesize data on the effects of an
intervention. Only 1 system was explicitly described for
use with a mixed‐method approach to research synthe-
sis.36 Eight of the systems described rating the quality of
a body of evidence primarily within the context of
research syntheses only, while 8 others described rating
the quality of a body of evidence for a guideline develop-
ment context. Only the GRADE approach addressed the
conceptual and procedural differences when using the
domains of evidence for assessing a body of evidence for
research synthesis versus guideline development
contexts.38
We identified inconsistencies in how included systems
labeled and defined the rating of the quality of a body of
evidence overall and the components of that rating. The
most frequently used terms to describe the overall rating
of the quality of a body of evidence were strength of evi-
dence, grades of evidence, quality, confidence, or certainty
in evidence.37,38,40,43-47 In contrast, the most commonly
used terms for assessing the conduct of individual
included studies were levels of evidence, critical appraisal,
quality appraisal, study limitations, risk of bias, and study
quality.37,43,44,48 From these, terms such as levels of evi-
dence, risk of bias, and study limitations were mainly
discussed regarding assessing studies for bias and internal
validity, while study quality, quality appraisal, and critical
appraisal were used to denote study execution more
broadly regarding eliminating threats to both internal
and external validities.
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MOVSISYAN ET AL. 113.3 | Defining quality of a body of evidence
Only 6 systems—3 of which are largely based on the
GRADE approach—provided a definition for the con-
struct of the quality of a body of evidence on intervention
effectiveness.38-41,46,47 In a systematic review context, the
GRADE approach and 3 derivative systems defined qual-
ity of a body of evidence as “the extent of confidence that
an estimate of the effect is correct.”38-40 The Guide to Com-
munity Preventive Services defined quality of a body of
evidence as “confidence that changes in outcomes are
attributable to the interventions”46 and the U.S. Preventive
Services Task Force (USPSTF) as the “likelihood that the
assessment of the net benefit (i.e., benefits minus harms)
of a preventive service is correct.”47 The USPSTF definition
is similar to how the GRADE approach defines the overall
quality of a body of evidence in the context of guideline
development, when considering all important outcomes
associated with the intervention, including harms. In this
context, GRADE defines the overall quality of a body of
evidence as “the extent of confidence that an estimate of
the effect is adequate to support a particular decision or
recommendation.”49
To assess the net benefit of a preventive service, the
USPSTF system uses analytic frameworks, also called
“chain of evidence” diagrams to map out the specific link-
ages in the overall chain of evidence that must be present
for a preventive service to be considered effective.47 The
system assesses the quality of a body of evidence for each
separate linkage in the chain of evidence to draw conclu-
sions about the overall effectiveness of a preventive ser-
vice. This approach is very similar to that adopted by the
GRADE‐modified Grading of Evidence for Public Health
Interventions (GEPHI) system.41 In addition to rating the
quality of a body of evidence for the estimates of the effect
of an intervention (which corresponds to the approach
described in GRADE), the GEPHI system suggests to also
rate the quality for the overall causal chain of an interven-
tion. This rating of the confidence in the overall causal
chain of an intervention is referred to as coherence of evi-
dence assessment in the GEPHI system.413.4 | Mapping of evidence domains
The evidence domains used to rate the quality of a body of
evidence were often similar in concept across systems yet
different in how they were described and operationalized.
We encourage readers to use Table 1 and Figure 1 as 2
complementary sources of information on the identified
evidence rating systems to examine the discrepancies
in labeling and describing evidence domains. Table 1 pro-
vides an overview of the domains of evidence as they
are reported in the original studies, while Figure 1 maps
12 MOVSISYAN ET AL.the 13 discrete domains we identified in included systems
and presents how they are reported in each of the included
systems. More information on how the specific evidence
domains were defined and operationalized in each system
is presented in Supporting Information (Online Supple-
ment). In the sections below, we briefly summarize the iden-
tified discrete set of domains of evidence (see Figure 1), as
well as the reported activities underpinning the develop-
ment and dissemination of these systems (see Figure 2).3.4.1 | Study design
Twelve systems included an evidence domain related to
the design of the individual studies constituting the body
of evidence. All but 4 of these systems35,36,45,50 described
an “evidence hierarchy” approach that influenced how
overall quality of a body of evidence was assessed. Proce-
durally, this entailed initially privileging a body of evi-
dence from certain study designs (namely RCTs) as
providing a higher quality (compared with other study
designs) before assessing other evidence domains. While
all systems with an evidence hierarchy approach placed
evidence from RCTs at the top of this hierarchy, many
further privileged specific nonrandomized study designs
over others. For example, the system used by the Joanna
Briggs Institute39 suggested initial ratings of quality
depending on whether a body of evidence consists of
experimental (Level 1), quasi‐experimental (Level 2), or
observational studies (Level 3). Similarly, the GRADE‐
modified GEPHI system for public health interventions
recommends that a body of evidence consisting of
nonrandomized studies with controls or before and after
[uncontrolled] studies have an initial rating of “moder-
ate” quality if these studies used methods to minimize
selection bias and confounding.413.4.2 | Study execution
Fifteen systems included an evidence domain related to
assessing how well studies constituting the body of evi-
dence were executed to minimize threats to internal and
external validities (also labeled as quality of study execu-
tion, risk of bias, study limitations, and study quality). In
most instances, however, systems mainly included criteria
to assess risks of bias or threats to the internal validity for
assessing study execution. A few systems, however, also
included specific criteria for assessing the generalizability
of the study results, that is, criteria related to the external
validity of the individual studies in the body of evidence.
Systems varied in how they operationalized assess-
ment of study execution. Some systems used design‐spe-
cific criteria, such as checklists or signaling questions for
appraising RCTs36,38,40,43 or longitudinal studies.43 Mostsystems, however, described more generic criteria to
assess study execution across various study designs
included in the body of evidence.37,45,46,48,503.4.3 | Consistency
Fourteen systems included an evidence domain related to
the consistency of evidence. Generally, systems defined
consistency as “the extent to which findings are similar
across included studies” in a body of evidence,48 usually
in reference to the degree of similarity in the magnitude
and/or direction of effect estimates. Most systems, how-
ever, did not report any specific criteria on how to rate
consistency in the body of evidence. Only a few systems
discussed specific procedures, such as statistical testing
for heterogeneity to rate consistency in the body of evi-
dence. The GRADE‐modified GEPHI approach distin-
guished between 2 types of consistency ratings41: The
first type was identical to the domain of the GRADE
approach termed as inconsistency and defined as “assess-
ment of statistical heterogeneity in the estimates of the
effect.”51 The second type of consistency rating was speci-
fied in the system as “consistency” assessment and was
defined as presence of “consistent evidence across a large
number of settings, geographical locations and diverse epi-
demiological study designs.” The system argued that the
fact that an intervention effect is reproducible under
highly variable conditions suggests reduced likelihood
that the observed effect is attributable to confounding or
bias.41 This can increase a reviewer's confidence in the
body of evidence regarding the overall effectiveness of
an intervention.3.4.4 | Measures of precision
Eleven systems included an evidence domain that we
have classified as relating to measures of precision of the
body of evidence: ie, considerations of the impact that
random error may have on effect estimates. Systems dif-
fered widely in the level of specification and sophistica-
tion they required for assessing precision of the body of
evidence. For instance, many systems recommend only
considering the number of studies in the body of evidence
as a measure of precision37,43,45,46,52; however, only 1 of
these systems specifies a threshold for the minimum num-
ber of studies to be included in the body of evidence.52
Furthermore, only the GRADE approach and its variants
described specific criteria for assessing precision regard-
ing the sufficiency of the sample size of the body of evi-
dence.38-41 These systems assessed sufficiency of the
sample size relative to an “optimal information size”: ie,
“number of patients (for continuous outcomes) and events
(for dichotomous outcomes) that would be needed to regard
MOVSISYAN ET AL. 13a body of evidence as having adequate power.”53 In addi-
tion, these systems also considered the boundaries of con-
fidence intervals for an effect estimate in relation to a null
effect and a clinically important effect threshold to make
an overall judgment about the precision of a body of evi-
dence. The estimate of the effect of an intervention is
judged to be less precise if the confidence interval is wide
to include a null effect or a threshold, which is considered
as clinically unimportant.533.4.5 | Directness
In general, the systems used concepts of directness, appli-
cability, and generalizability of evidence interchangeably
and inconsistently—often without providing clear defini-
tions or specific criteria to guide the assess-
ment.35,37,47,48,50 In addition, these terms were not
necessarily used as synonyms across the systems. For
example, the system endorsed by the National Health
and Medical Research Council of Australia used the term
“applicability” to address whether the body of evidence
was relevant to the local context (including the organiza-
tional and cultural contexts), while the term generaliz-
ability was used to refer to how precisely a body of
evidence answered a review or a guideline question in
populations and settings of interest.48 To disentangle the
discrepancies in the terminology, we have used the termi-
nology of the GRADE approach, namely, “directness” of
evidence, to describe the domains of evidence from the
included systems related to the notion of comparability
of the evidence to the original research question. We have
identified 6 systems that used this domain of evidence to
assess how directly the available evidence answers a
review or a guideline question regarding Population,
Intervention, Comparison, and Outcomes elements of
the question.35,39-41,48,543.4.6 | Publication bias
Five systems included publication bias as a domain for rat-
ing the quality of a body of evidence.36,39-41,55 All but 1 of
these systems followed a definition of publication bias as
used within the GRADE approach, that is, “a failure to
identify studies as a result of studies remaining unpublished
or obscurely published.”55 The system used by AHRQ, on
the other hand, considered publication bias as only 1 type
of potential bias within a broader domain of reporting
biases, which was itself defined as a decision by authors
or journals to report research findings based on their
direction and magnitude of effect.40 Selective outcome
reporting and selective analysis reporting were the other
types of reporting biases described in this system.3.4.7 | Magnitude of effect
We identified 7 systems, which included magnitude of
effect as a distinct domain to rate the quality of a body of
evidence on the effectiveness of health or social interven-
tions.36,39-41,43,46,56,57 However, only 4 of these systems
specified the thresholds for what they considered to be a
“large” magnitude of effect.39,41,56,57 This predominantly
included a relative risk greaten than 2, or less than 0.2,
as suggested in the GRADE approach.563.4.8 | Dose‐response
Overall, 5 systems considered dose‐response as a distinct
domain of evidence when rating the quality of a body of
evidence on the effectiveness of health or social interven-
tions.39-41,47,56,57 The systems commonly defined dose‐
response as a “pattern of a larger effect with greater expo-
sure to an intervention.”40
3.4.9 | Plausible residuals
All systems that followed the structure of the GRADE
approach (overall 4 systems, including GRADE itself)
considered counteracting confounding, as a domain to
upgrade the quality of a body of evidence, when a body
of evidence is mainly composed of observational
studies.39-41,56 Two possibilities were commonly applied:
“if all plausible residual biases would diminish the observed
effect, or if all plausible residual biases would suggest a spu-
rious effect when no effect is observed.”56
3.4.10 | Analogy
Only 1 system—the GEPHI system—included an evi-
dence domain related to analogous evidence. The GEPHI
system operationalized analogous evidence as supporting
evidence from similar or “analogous” interventions that
are known to operate through the same or similar mech-
anisms, which, if present, could lead to a higher quality
of a body of evidence rating.41 In the context of WHO
guidelines on indoor air quality, the system discusses the
example of how certainty in the effects of household air
pollution from solid fuel can be enhanced by strong
empirical evidence about the effects of second‐hand or
active smoking. In this example, both household air pollu-
tion and second‐hand or active smoking expose individ-
uals to similar combustion mixtures and therefore are
viewed as analogous pieces of evidence.41
3.4.11 | Robustness
Robustness of evidence was described as a domain to rate
the quality of a body of evidence by one system.52 The
14 MOVSISYAN ET AL.system suggests that reviewers measure robustness of evi-
dence through sensitivity analysis with a priori defined
thresholds. For example, a reviewer may decide a priori
that a threshold for robustness assessment is one in which
“confidence intervals of the last three cumulative, random‐
effects meta‐analyses remain fully on the same side of zero
after removing of the study with the smallest weight.”523.4.12 | Applicability
Four systems described applicability as a domain of evi-
dence measuring the extent to which evidence may be
applicable in a specific context.37,47,48,50 It is worth
highlighting that we identified 3 additional systems,40,45,46
which considered applicability of evidence as a separate
judgment when making recommendations for practice.
In these systems, discussion of applicability was held sep-
arately from other domains of evidence, and largely
within a context of guideline development. For example,
the GRADE‐based system endorsed by AHRQ clearly sep-
arates judgments of directness of evidence from that of
applicability assessment. In this system, directness of evi-
dence is defined to express “how closely the available mea-
sures an outcome of interest” and relies on 2 judgments40:
the directness of the employed outcomes (ie, whether the
available evidence is in fact only a proxy for an ultimate
outcomes of interest) and directness of comparisons (ie,
whether evidence derives from head‐to‐head compari-
sons). Meanwhile, the system defines applicability as the
external validity of the evidence base regarding different
populations and is considered explicitly but separately
from the overall rating of the quality of a body of
evidence.403.4.13 | Coherence
Only 3 systems included an evidence domain related to
assessing the coherence of the causal pathway of an inter-
vention41,47,57: that is, related to the assessment of a the-
ory of change or a mechanism whereby an intervention
is expected to operate. The GEPHI system recommends
assessing confidence in the overall causal pathway
between an intervention and distal outcomes (referred to
as rating of coherence of evidence) regarding the evidence
informing each individual link in the causal pathway.41 It
describes this domain specifically in the context of inter-
ventions that involve complex causal pathways, where
evidence directly linking the intervention with the distal
outcomes is frequently unavailable. Similarly, by using
analytic frameworks, the USPTSF system rates certainty
of evidence in the overall chain of evidence for a specific
preventive service.47 The system described by Tang and
colleagues (2008) included assessment of the knownmechanisms of action as a domain of evidence for rating
of the quality of a body of evidence: “if the theoretical basis
is not known, the strength of evidence will be less
convincing.”573.5 | Development and dissemination of
the evidence rating systems
Figure 2 describes how the authors report procedures
underpinning the development and dissemination of the
systems. Regarding the preparatory activities for develop-
ing the system, only 4 systems empirically demonstrated
the need for developing a new evidence rating system by
referring to a separate publication by the same research
team providing a critical appraisal of existing sys-
tems.38,43,45,48 More frequently, the systems reported par-
ticipants involved in the development of the system, and
only 4 systems described obtaining funding for developing
the system.36,48,50,52 None reported conducting a Delphi
process to develop the system, and only 5 reported hosting
an expert meeting. However, with the exception of the
GRADE approach, these systems did not provide further
details on how these meetings were organized.38,44,48,50,58
The GRADE Working Group, on the other hand, orga-
nizes annual meetings lasting 2 to 3 days, where members
of the group have an opportunity to meet face‐to‐face and
further discuss and develop and refine aspects of the
GRADE methodology.7
Regarding the write‐up and dissemination activities,
only 3 systems described how the publication introducing
the system was developed,44,48,50 while instructions for
using the systems were predominantly described in the
same document that introduced it. In 6 instances, willing-
ness to incorporate the feedback of users and update the
systems was mentioned.37,38,40,43,44,48 Finally, although
most systems are available online, information regarding
adherence to or translation of the systems was not
reported for any system except for GRADE (further details
on this can be found on the website of the GRADE Work-
ing Group).7 The GRADE approach was also unique in
involving ongoing working groups aiming to continually
advance and expand the applicability of its methodology
in step with developments in the area of evidence synthe-
sis and assessment.4 | DISCUSSION
4.1 | “State of the field” map of evidence
rating systems for health and social
interventions
This systematic review set out to describe the content,
development, and dissemination of the systems for rating
MOVSISYAN ET AL. 15the quality of a body of evidence on intervention effective-
ness across health and social policies. The review identi-
fied 17 systems that have made useful contributions to
rating the quality of a body of evidence in health and
social research synthesis. While this review identified
domains of evidence that were commonly reported across
the systems, there was significant variation in the specifi-
cations for these domains. The systems used different ter-
minology to denote similar constructs of evidence when
rating the quality of a body of evidence. The systems also
varied in how they operationalized the domains of evi-
dence, that is, in whether they described specific criteria
and provided guidance for assessing each domain in an
operationalizable manner. This review also identified
domains of evidence that were found only in a few sys-
tems (see Figure 1). In general, the discrete set of domains
identified in our review can be viewed to largely follow
the “viewpoints for causation” proposed by Sir Austin
Bradford Hill,59 although the relative coverage of these
criteria across the included systems varies. For example,
domains of evidence that will correspond to the Hill's
criteria of experiment (study design and study execution),
strength of association (magnitude of effect), consistency,
and dose‐response gradient have been reported more
extensively in evidence rating systems. Meanwhile, our
review found only 3 systems, which considered domains
corresponding to the Bradford Hill viewpoints of plausi-
bility and coherence of evidence, and only 1 system
included a domain on the analogous evidence. This can
partly be explained by the challenges of developing an
operational framework in research synthesis to assess
the evidence against these criteria, including the need to
search and integrate different sources of evidence.60
As this systematic review aimed to consider evidence
rating systems across health and social policies, the iden-
tified variation in the terminology and description of evi-
dence domains may partly reflect how research synthesis
and its practice differs across policy areas and types of
interventions. One of the most contested topics in the dis-
cussions of the quality of a body of evidence relates to the
hierarchy of evidence initially described in the paradigm
of evidence‐based medicine as an approach to differenti-
ate between weak and strong study designs for assessing
intervention effectiveness.61 While different versions of
the evidence hierarchy have been described in clinical
medicine, all of them place study designs such as case
series (considered relatively weaker in protecting against
threats to internal validity) in the bottom of the hierarchy,
followed by case‐control and cohort studies in the middle
and RCTs at the top.62 As our findings demonstrate, this
evidence hierarchy approach is still used in many evi-
dence rating systems, and particularly those developed
and employed in clinical medicine. The widely adoptedGRADE approach also follows this approach by way of
describing 2 broad categories of study designs as a starting
point for the body‐of‐evidence rating process (RCT evi-
dence is initially rated as “high” quality and non‐RCT evi-
dence as “low” quality). By contrast, our findings show
that systems which are used in broader policy areas, such
as public health, tend to allow more flexibility for differ-
entiating between the many types of non‐RCT designs
within their constructions of evidence hierarchies (see
section 3.4.1 and Table 1). This practice is commensurate
with a view that quasi‐experimental approaches should be
given appropriate provisions in evidence rating systems as
valuable methods for making causal inferences for public
health interventions.63
Consistency of the body of evidence was another fre-
quently reported domain of evidence in the included sys-
tems. Our findings demonstrate that evidence rating
systems currently conceptualize consistency as similarity
in the magnitude and direction of effect estimates across
studies (of same or similar design) included in the body
of evidence. There are, however, concerns that this
approach only partly reflects the central tenet of scientific
method, specifically that findings are replicable across “a
variety of situations and techniques.”59 From this perspec-
tive, there are suggestions for a broader interpretation of
the consistency of evidence to also consider “triangulation
of evidence” across different methodological approaches
when arriving at overall conclusions about intervention
effectiveness.64 Triangulation has been defined as integra-
tion of evidence from several different methodological
approaches (different study designs and analytical
approaches), which address the same underlying causal
question, but which vary in key sources of potential bias
(for example, multivariable regression, instrumental vari-
ables, and RCTs).65 The importance of evidence triangula-
tion has been cogently argued in the context of public
health interventions involving longer causal pathways
and multiple targets and behaviors, such as smoking or
alcohol consumption, which are difficult (or impossible)
to evaluate with RCTs alone. When the results from dif-
ferent methodological approaches are consistent in that
they all point to the same conclusion, this is argued to
strengthen the confidence in the overall findings (see
Lawlor et al., 2016).65 Our review identified only 1 system
which extended the domain of consistency to consider
evidence from different study designs.41 Its broad inter-
pretation, which looks at evidence from different method-
ological approaches to inform the rating of the quality of a
body of evidence, was unique within our findings (see sec-
tion 3.4.3).
Our review identified very few instances where the
systems provided a definition for the construct of the
quality of the body of evidence (see section 3.3). The few
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16 MOVSISYAN ET AL.reported definitions mainly focus on the confidence in a
direct estimate of the effect of an intervention—a defini-
tion initially suggested by GRADE. It is worth noting here
that the most recent publication of the GRADE Working
Group clarifies this definition of the quality of a body of
evidence based on a priori defined threshold and the con-
text of the review.66The quality of a body of evidence is
currently conceptualized to reflect the extent to which
reviewers can be confident that “the true effect for a spe-
cific outcome lies on one side of a specified threshold or
within a chosen range.”66 The revised guidance suggests
3 types of ratings: noncontextualized, partly contextual-
ized, and fully contextualized (see Table 2 for more
details). In this new conceptualization, the quality of a
body of evidence ratings is explicitly acknowledged to be
contingent upon a priori defined thresholds of what may
be considered as meaningful effects in different contexts.
These thresholds and the resultant ratings may therefore
vary depending on the context and purpose of the review.
Regarding the activities underpinning the develop-
ment and dissemination of the included systems, our
review found that most systems did not report a compre-
hensive literature review or a consensus‐based procedure
for developing the system (see Figure 2). In a similar vein,
we found little reporting of how these systems were writ-
ten up and further disseminated. It therefore remains dif-
ficult to assess how the described domains of evidence
have been conceptualized and the degree to which they
are, or are not, the product of scientific consensus. In
the meantime, if not properly developed and dissemi-
nated, these systems may have limited value and use in
research synthesis.26 In this regard, our review shows that
the GRADE approach is 1 of the most comprehensive and
transparent evidence rating systems in its guidance as
well as its development and dissemination.7T
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This review's unique contribution may lie in its thorough
exploration of the content, development, and dissemina-
tion of the existing systems for rating the quality of a body
of evidence across a range of policy areas, following sys-
tematic searches of bibliographic databases and sources
of gray literature. Consequently, this review provides a
comprehensive inventory of evidence domains considered
when assessing quality of a body of evidence in research
syntheses on intervention effectiveness across not just
health, but social policy as well. Considering the
acknowledged challenges associated with locating evi-
dence rating systems through formal literature searches,22
we decided to balance the searches of scientific databases
with an extensive search of gray literature, including 83
websites and databases of key stakeholder organizations.
MOVSISYAN ET AL. 17Furthermore, we complemented these searches with
expert consultations to help locate these additional
sources.
We note several limitations worth considering when
interpreting our findings. First, we had to limit the scope
of our review because of practical considerations. For
instance, we included documents published in English
only and therefore might have missed relevant work from
the non‐English literature. Furthermore, given the identi-
fied variation in the terminology of the evidence domains,
the mapping of these domains necessarily involved a
degree of interpretation. It is therefore possible that
another team of reviewers might have produced a differ-
ent mapping of the domains with different conceptual cat-
egories. For example, another review team may have
interpreted the broad evidence domain of the “efficacy
data” of the Highest Attainable Standard of Evidence sys-
tem58 as referring to the strength of association and there-
fore in the map classified under the category of the
“measures of precision,” rather than consistency as we
currently did. To address this concern, the initial mapping
of evidence domains by the first author was indepen-
dently verified by a second reviewer, and all issues were
further discussed and clarified in the team.4.3 | Concluding remarks
The mapping of evidence domains presented in this
review aims to clarify how domains of evidence for rating
the quality of a body of evidence on intervention effective-
ness have been specified, developed, and disseminated
across health and social policies. We see 2 broad applica-
tions of our mapping of evidence domains. First, it can
serve as an aid for researchers to help choose the evidence
rating system and corresponding domains of evidence
most suitable for their research focus and context of work.
Second, by delineating important gaps in the content,
development, and dissemination of current systems, it
can indicate areas that may need further methodological
development. It is worth noting that our mapping of
domains should not be regarded as an expert advice on
the best system for assessing the quality of a body of evi-
dence on intervention effectiveness, but rather should be
considered as a “state of the field” description and inter-
pretation of the content and the processes of development
and dissemination based on the information reported in
the included systems.ACKNOWLEDGEMENTS
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